Implementations by Phenotype

Title Phenotype Institution Algorithm Type Total Cases Total Controlssort descending PPV Sensitivity
NU BMI for PRS Body Mass Index (BMI) Northwestern University Case, Control
AMI/1st AMI Vanderbilt Implementation Statins and MACE Vanderbilt University Case Only 50 96%
CDiff NU implementation - May 2012 chart review Clostridium Difficile Colitis Northwestern University Case, Control 90%, 95% 95%
NU migraine for eMERGEseq population Migraine Northwestern University Case, Control
Clopidogrel Poor Metabolizers-Columbia Clopidogrel Poor Metabolizers Columbia University Case Only
MCRI - Breast CA Implementation Breast Cancer Case Only
CKD for NU eMERGEseq subjs Chronic Kidney Disease Northwestern University Case, Control
GHUW Diverticulitis Diverticulosis and Diverticulitis GHRI/UW Case, Control
NU CRF e3 update Cardiorespiratory Fitness Algorithm (eMERGE Mayo Network Phenotype) Northwestern University Case Only 1,572
Dementia Implementation - Columbia Dementia Columbia University Case Only 137
Mayo SLE Implementation SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria Mayo Clinic Case, Control 0 0
CHOP Post-event Pain Post-event Pain algorithm CHOP Case, Control 99 2 96%
Early Childhood Obesity Implementation - Columbia Severe Early Childhood Obesity Columbia University Case, Control 2 3
Marshfield C-diff implementation Clostridium Difficile Colitis Marshfield Clinic Research Foundation Case, Control 21 10 100%, 100%
Marshfield Zoster implementation Herpes Zoster Marshfield Clinic Research Foundation Case, Control 10 10 100%, 100%
Validation of Asthma algorithm - Geisinger Asthma Geisinger Case, Control 10 10 100%, 100%
Geisinger c.Diff eMERGE3 Implementation Clostridium Difficile Colitis Geisinger Case, Control 20 20 100%, 100% 100%, 100%
Appendicitis Case 1, Control Appendicitis Cincinnati Children's Hospital Medical Center Case, Control 15 20 93%, 100%
Marshfield AAA implementation Abdominal Aortic Aneurysm ( AAA ) Marshfield Clinic Research Foundation Case, Control 25 22 100%, 100%
Marshfield Hearing loss validation Hearing Loss Marshfield Clinic Research Foundation Case, Control 25 25 100%, 100%
Group Health/University of Washington CRC Validation Colorectal Cancer (CRC) GH/UW Case, Control 25 25 92%, 100% 100%, 100%
Statin and MACE Mount Sinai Implementation Statins and MACE Mount Sinai Case Only 52 25 96%, 100% 100%, 100%
Marshfield ACE-I cough implentation ACE Inhibitor (ACE-I) induced cough Marshfield Clinic Research Foundation Case, Control 25 25 100%, 96%
Implementation For Phase 3 eMERGE Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia Geisinger Case, Control 25 25 100%, 96%
Geisinger Impl Colorectal Cancer (CRC) Geisinger Case, Control 25 25 100%, 100%

Pages